JACOB KLAUSTERMEIER: Open Payments
NPI 1952560443 · CRYSTAL LAKE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 172 payments from 15 companies in 2025. Trend: 2023 $3,407 · 2024 $3,932 · 2025 $3,441
Food & beverage: $3,348Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $818 |
| Janssen Biotech, Inc. | 33 | $460 |
| UCB, Inc. | 12 | $423 |
| Novartis Pharmaceuticals Corporation | 14 | $303 |
| Regeneron Healthcare Solutions, Inc. | 9 | $277 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $243 |
| Organon LLC | 15 | $187 |
| GENZYME CORPORATION | 5 | $172 |
| Lilly USA, LLC | 7 | $153 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $121 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, RINVOQ, COSENTYX, ILUMYA, TALTZ.
Industry payments across IL — which companies pay providers there.
